Obtenga las últimas noticias sobre las acciones de MediciNova con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de MNOV

Últimas noticias sobre

MediciNova

MediciNova Inc

ABVC BioPharma

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

aTyr Pharma

BeyondSpring

Cibus

Connect Biopharma Holdings Limited - Ordinary Shares

Connect Biopharma Hldgs

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

Fortress Biotech

Immunic

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Lite Strategy

Metagenomi

PMV Pharma

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Repare Therapeutics

Sutro Biopharma

TScan Therapeutics

Tevogen Bio Holdings

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

XBiotech

MediciNova (MNOV) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Comments

MediciNova Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL